ACCESS Newswire

    / Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (“LOI”) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.

    Latest News

    – Kenya aims to raise its annual coffee output to 150,000 metric tonnes, with new climate-resilient varieties expected to play a central role. Production is projected at about 60,000 metric tonnes in the 2025/2026 season, well short of that target.